Brief: Collegium Pharmaceutical Executes Master Settlement Agreement Resolving All 27 Pending Opioid-Related Lawsuits Brought Against Co
March 30 (Reuters) - Collegium Pharmaceutical Inc COLL.O :
* COLLEGIUM PHARMACEUTICAL - EXECUTED MASTER SETTLEMENT
AGREEMENT
RESOLVING ALL 27 PENDING OPIOID-RELATED LAWSUITS BROUGHT AGAINST
CO
* COLLEGIUM PHARMACEUTICAL INC - PAID $2.75 MILLION TO
PLAINTIFFS
AND CASES WILL BE DISMISSED, WITH PREJUDICE, IN COMING WEEKS
* COLLEGIUM PHARMACEUTICAL - ENTERED INTO MASTER SETTLEMENT
AGREEMENT TO EFFICIENTLY RESOLVE LITIGATION WITHOUT ADMISSION OF
LIABILITY OR WRONGDOING
Source text for Eikon: ID:nGNXwHp6T
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%